Over the next 15 years chronic disease like cancer and heart disease will become major killers in Sub-Saharan Africa. A new report from the Economist Intelligence Unit explains why.

Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.

Ambitious scientist accelerates research into African genomic diversity and health challenges with internship

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Our Global Head of Patient Affairs and Policy shares why it’s critical to engage patients throughout the drug development process.

The current refugee crisis is one of the world's greatest humanitarian challenges. Svitlana shares her story of her journey to Novartis and how her work as part of the Giving and Volunteering team is opening the doors to refugees and other marginalized groups and allowing our people to make a difference by helping those who are most vulnerable.